Amedisys (NASDAQ:AMED) Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Amedisys (NASDAQ:AMED) released its earnings results on Wednesday. The health services provider reported $0.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by ($0.09), Zacks reports. The business had revenue of $598.05 million during the quarter, compared to the consensus estimate of $602.38 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%.

Amedisys Stock Up 0.2 %

AMED opened at $91.68 on Thursday. The company has a 50 day moving average of $91.11 and a 200 day moving average of $93.27. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a market cap of $3.00 billion, a PE ratio of 36.27, a price-to-earnings-growth ratio of 1.78 and a beta of 0.73.

Analyst Upgrades and Downgrades

Separately, Stephens reissued an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a report on Wednesday, February 12th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.